To what extent can binding studies allow the quantification of affinity and efficacy?

被引：6

作者：

Birdsall, NJM ^{[1
]}

Lazareno, S ^{[1
]}

机构：

[1] MRC, CTR COLLABORAT, LONDON NW7 1AA, ENGLAND

来源：

RECEPTOR CLASSIFICATION: THE INTEGRATION OF OPERATIONAL, STRUCTURAL, AND TRANSDUCTIONAL INFORMATION | 1997年 / 812卷

关键词：

D O I：

10.1111/j.1749-6632.1997.tb48144.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：41 / 47

页数：7

共 33 条

[1] BENOVIC JL, 1988, J BIOL CHEM, V263, P3893
[2] BIOCHEMICAL STUDIES ON MUSCARINIC ACETYLCHOLINE RECEPTORS
BIRDSALL, NJM
HULME, EC
[J]. JOURNAL OF NEUROCHEMISTRY, 1976, 27 (01) : 7 - 16
[3] BIRDSALL NJM, 1978, MOL PHARMACOL, V14, P723
[4] BINDING OF AGONISTS AND ANTAGONISTS TO MUSCARINIC RECEPTORS
BIRDSALL, NJM
BURGEN, ASV
HILEY, CR
HULME, EC
[J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1976, 4 (03): : 367 - 371
[5] C FRAGMENT OF LIPOTROPIN HAS A HIGH AFFINITY FOR BRAIN OPIATE RECEPTORS
BRADBURY, AF
SMYTH, DG
SNELL, CR
BIRDSALL, NJM
HULME, EC
[J]. NATURE, 1976, 260 (5554) : 793 - 795
[6] BURGEN ASV, 1974, BRIT J PHARMACOL, V51, pP127
[7] COLQUHOUN D, 1987, PERSPECTIVES RECEPTO, P103
[8] COSTA T, 1992, MOL PHARMACOL, V41, P549
[9] COSTA T, 1990, MOL PHARMACOL, V37, P383
[10] DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369